Overview
Wen-pin Cheng practices practicing medicine in Taiwan.
Their clinical expertise encompasses Cerebral Hypoxia, Squamous Cell Lung Carcinoma, Pulmonary Edema, and Keloids.
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Wen-pin Cheng
Is Wen-pin Cheng a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Wen-pin Cheng is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Wen-pin Cheng participate in research or clinical trials?
Yes. Wen-pin Cheng has published 14 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Wen-pin Cheng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaCheng isExperienced. Learn about Cerebral Hypoxia.
- KeloidsCheng isExperienced. Learn about Keloids.
- Pulmonary EdemaCheng isExperienced. Learn about Pulmonary Edema.
- Squamous Cell Lung CarcinomaCheng isExperienced. Learn about Squamous Cell Lung Carcinoma.